Research Feed

OTEX traded down -29% in the last month to $22.79 (RSI 8, oversold extreme). Stock is now 42% below the lowest analyst price target ($27.89) and 70% below mean target ($38.72). Forward P/E compressed to 5.1x with 4.6% dividend yield. The Q2 10-Q filed today shows improving cash fundamentals but real

OTEX trading at RSI 12.9 (extreme oversold), forward P/E 5.72, down 20% in 1 month. Earnings Feb 5 (3 days). Active deleveraging under interim CEO: $313M in non-core divestitures (eDOCS + Vertica) for debt paydown. 4 consecutive earnings beats (avg +12.6%). Every analyst target above current price (